ClinicalTrials.Veeva

Menu

Preemptive Low-dose Epidural Ketamine for Preventing Chronic Post-thoracotomy Pain

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Chronic Post-thoracotomy Pain

Treatments

Drug: ketamine free
Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT01017393
JHBahk_epidural ketamine PTPS

Details and patient eligibility

About

Chronic post-thoracotomy pain is the most common long-term complication that occurs after a thoracotomy with a reported incidence of up to 80%. While thoracic epidural analgesia has become the mainstay for managing acute post-thoracotomy pain, its effect on the chronic post-thoracotomy pain seems questionable. The objective of this prospective, double-blinded, randomized, controlled trial was to assess the effect of preemptive low-dose epidural ketamine in addition to preemptive thoracic epidural analgesia on the incidence of chronic post-thoracotomy pain.

Enrollment

209 patients

Sex

All

Ages

19 to 81 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing surgery with a thoracotomy incision

Exclusion criteria

  • history of previous thoracic surgery, chronic pain, psychiatric disease, cardiac or vascular disease, neurologic deficits, or contraindications to epidural catheterization such as coagulopathy, or localized or systemic infection

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

209 participants in 2 patient groups

ketamine
Experimental group
Description:
epidural ketamine added to the patient controlled epidural analgesia regimen
Treatment:
Drug: Ketamine
ketamine free
Active Comparator group
Description:
epidural ketamine NOT added to the patient controlled epidural analgesia regimen
Treatment:
Drug: ketamine free

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems